ESSANCE
The computed 12-month bankruptcy probability of ESSANCE is 0.4% (very low). The 2024 annual accounts show equity of €92k and a net result of €-61k. Equity is growing by ~2113% per year across the filed fiscal years. Its solvency ranks better than 14% of 6546 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €92k |
| Net result | €-61k |
| Staff (FTE) | 1 |
| Better than sector | 14% |
Fragile profile, watch profitability in particular.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 14.6% | 66.7% | |
| Net result | €-61k | €46k | |
| Equity | €92k | €79k | |
| Gross operating margin | €73k | €79k | |
| Staff costs | €65k | €21k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-22k |
| Net profit | €-61k |
| Cash flow | €-29k |
| Staff costs | €65k |
| Income taxes | - |
| Dividends | - |
| Total assets | €629k |
| Equity | €92k |
| Debt | €538k |
| of which ≤ 1y | €237k |
| of which > 1y | €295k |
| Working capital | €-22k |
| Employees (FTE) | 1.0 |
| 2024 | |
|---|---|
| Current ratio | 0.91 |
| Quick ratio | 0.59 |
| Working capital ratio | -3.5% |
| Solvency | 14.6% |
| Debt / equity | 5.87 |
| Long-term debt ratio | 3.22 |
| Interest coverage | -3.23 |
| Gross margin | - |
| Net margin | - |
| ROA | -9.6% |
| ROE | -66.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €629k |
| Fixed assets | 21/28 | €410k |
| Formation expenses | 20 | €4k |
| Intangible fixed assets | 21 | €44k |
| Tangible fixed assets | 22/27 | €366k |
| Current assets | 29/58 | €215k |
| Stocks & contracts in progress | 3 | €75k |
| Amounts receivable within one year | 40/41 | €33k |
| Cash & bank | 54/58 | €103k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €629k |
| Equity | 10/15 | €92k |
| Contributions / capital | 10/11 | €200k |
| Accumulated profits (losses) | 14 | €-108k |
| Amounts payable | 17/49 | €538k |
| Amounts payable after one year | 17 | €295k |
| Amounts payable within one year | 42/48 | €237k |
| Trade debts payable within one year | 44 | €26k |
| Income statement | ||
| Gross operating margin | 9900 | €73k |
| Operating result | 9901 | €-54k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €7k |
| Result before taxes | 9903 | €-61k |
| Net result for the period | 9904 | €-61k |
| Result to be appropriated | 9905 | €-61k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 28-09-2021 |
| Status | Active |
| Postal code | 3800 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71352D0930/00F017 | Flanders | 1,672 m² | 1 · 262 m² | 8.6 m · 2 fl. |
| 71304E0883/00D000 | Flanders | 1,573 m² | 1 · 346 m² | 12.0 m · 2 fl. |
| 71022H0567/00L004 | Flanders | 678 m² | 1 · 595 m² | 13.1 m |
| 71053H0982/00B000 | Flanders | 141 m² | 1 · 141 m² | 15.2 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
04-02-2025 DOKTERSPRAKTIJK JULIE NASSEN BV resigns as director
- DOKTERSPRAKTIJK JULIE NASSEN BV, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": "0649.425.391",
"name": "DOKTERSPRAKTIJK JULIE NASSEN BV",
"address": "Grendelweg 11, 3570 Alken",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-10-30",
"evidence_quote": "De vergadering beslist om de huidige bestuurder, DOKTERSPRAKTIJK JULIE NASSEN BV, met zetel te 3570 Alken, Grendelweg 11, ingeschreven in het rechtspersonenregister te Antwerpen, afdeling Tongeren, met ondernemingsnummer 0649.425.391, met vaste vertegenwoordiger Mevr. Julie Nassen woonachtig te Gren",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2025-01-27",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2024-12-14",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0774.699.012",
"name_full": "ESSANCE",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}04-12-2024 Capital increase of €150,000 to €150,000
- €0 → €150.000
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 150000.0,
"delta_eur": 150000.0,
"before_eur": 0.0,
"_arith_derived": "before",
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 150000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
}
],
"notary": {
"name": "Marc JANSEN",
"firm_city": null,
"firm_name": "MARC JANSEN \u0026 ARVID LEROI, geassocieerde notarissen",
"office_city": "Hasselt",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-12-04",
"filing_date": "2024-12-01",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-10-29",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": "2024-10-29"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0774.699.012",
"name_full": "ESSANCE",
"legal_form": "Besloten Vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"eensluidend afschrift",
"verklaring eenhoofdigheid"
],
"shareholders_after": [],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | ESSANCE |